http://www.zibb.com/all/theme/cq/Watson+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Sun, 20 Sep 2009 18:45:25 GMTSun, 20 Sep 2009 18:45:25 GMT608831http://www.zibb.com/all/theme/cq/Watson+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.bio-medicine.org/medicine-news-1/Despite-ongoing-safety-concerns--study-finds-adverse-reactions-from-contrast-agents-rarely-occur-57720-1/Health, ...Iodinated and Gadolinium based contrast agents frequently used during...The study performed at the Mayo Clinic in Rochester MN included a t... Contrast agents are very safe to use and they are often essential in ... While contrast reactions can occur it is important to note thathttp://www.bio-medicine.org/medicine-news-1/Despite-ongoing-safety-concerns--study-finds-adverse-reactions-from-contrast-agents-rarely-occur-57720-1/Watson Pharmaceuticals IncorporatedSun, 20 Sep 2009 18:45:25 GMThttp://www.watsonpharm.com/Site Map | © Copyright 1998- Watson Pharmaceuticals, Inc. All rights reserved. Legal/Copyright Disclaimer | Privacy Policy Copyright© 1998- MarketWatch.com Inc. User agreement applies. Historical and current end-of-day data provided by Interactive Data Corp.http://www.watsonpharm.com/Watson Pharmaceuticals Incorporatedhttp://www.zibb.com/article/3786284/Video+Stocks+to+Watch+Starbucks+Hansen+Natural+Watson+PharmaceuticalsStarbucks CEO Nelson Peltz to Sell Stake in Company, Shares Rise Near 4%; Peltz to Add Shares of Hansen Natural, Shares Rise 11%; Carl Icahn May Be Building Stake in Watson Pharmaceuticals http://www.clipsyndicate.com/video/playlist/1998/668361?cpt=8&wpid=523http://www.zibb.com/article/3786284/Video+Stocks+to+Watch+Starbucks+Hansen+Natural+Watson+PharmaceuticalsWatson Pharmaceuticals IncorporatedThu, 14 Aug 2008 18:32:00 GMThttp://www.watson.com/disclaimer.aspThank you for visiting this Watson Web site. This site may not be used as a supplement or alternative for healthcare. The information provided is merely for educational purposes and its accuracy is not guaranteed. Do not use this site as a substitute for medical care or medical advice.http://www.watson.com/disclaimer.aspWatson Pharmaceuticals Incorporatedhttp://www.biz-lib.com/ZPH98455.htmlPartneringdesk Watson Pharmaceuticals, Inc. and Company Deals Briefing is a business development and licensing report written to support your partnering and strategic decisions.http://www.biz-lib.com/ZPH98455.htmlWatson Pharmaceuticals Incorporatedhttp://www.computerbusinessreview.com/companyprofile.asp?guid=27BC3B94-7077-4222-9466-0AF34C99996F** NEW FEATURE ** Sign-up for NewsAlerts on Watson Pharmaceuticals, Inc. so that whenever news breaks on this company you are amongst the first to know. Click here...http://www.computerbusinessreview.com/companyprofile.asp?guid=27BC3B94-7077-4222-9466-0AF34C99996FWatson Pharmaceuticals Incorporatedhttp://www.newsrx.com/health-articles/790616.html',250)" onMouseout="hideddrivetip()">U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of YAZ(R) tablets prior to the expiration of patents owned by Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc. (Bayer).http://www.newsrx.com/health-articles/790616.htmlWatson Pharmaceuticals Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-WPI.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-WPI.htmWatson Pharmaceuticals Incorporatedhttp://www.researchandmarkets.co.uk/reportinfo.asp?report_id=307761Partneringdesk Watson Pharmaceuticals Inc Deals Briefing provides an in-depth view of the 31 deals made by Watson Pharmaceuticals Inc and its subsidiaries with 32 partnering companies between 2001 and 2006, in a clear and accessible PDF format.http://www.researchandmarkets.co.uk/reportinfo.asp?report_id=307761Watson Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/307718Partneringdesk Genzyme Corporation Deals Briefing provides an in-depth view of the 92 deals made by Genzyme Corporation and its subsidiaries with 104 partnering companies between 2001 and 2006, in a clear and accessible PDF format.http://www.researchandmarkets.com/reports/307718Watson Pharmaceuticals Incorporatedhttp://www.eyeforpharma.com/print.asp?news=43566ALLENTOWN, Pennsylvania (October 06, 2004) -Watson Pharmaceuticals has licensed Target Software's Target SFA mobile pharmaceutical sales software suite. The suite is being implemented for Watson's entire field sales force.http://www.eyeforpharma.com/print.asp?news=43566Watson Pharmaceuticals Incorporatedhttp://www.newratings.com/headlines/Watson-Pharmaceuticals_US9426831031.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Watson-Pharmaceuticals_US9426831031.htmlWatson Pharmaceuticals Incorporatedhttp://www.canbiotech.com/home.asp?max_portlet=8&pId=14_32Participating on CanBiotech's Networks Using the Site Privacy & Security Statement Service Provider Spotlight/Showcase Guide Advertise with us Directory Guide & Access Policy News Postings Event Postings CanBiotech Newsletters © 2000-2008 CanBiotech™ Inc.http://www.canbiotech.com/home.asp?max_portlet=8&pId=14_32Watson Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=27224(U.S.) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for levonorgestrel / ethinyl estradiol tablets USP, 0.15 mg / 0.03 mg.http://www.pharmacychoice.com/News/article.cfm?Article_ID=27224Watson Pharmaceuticals Incorporatedhttp://www.datatrans-inc.com/index.php?action=tp&id=81You can become EDI capable with Watson Pharmaceuticals within one business day with DataTrans easy to use WebEDI program. The only requirement is that you have access to the internet no software to maintain and no hardware requirements.http://www.datatrans-inc.com/index.php?action=tp&id=81Watson Pharmaceuticals Incorporatedhttp://www.thelabrat.com/jobs/companies/WatsonPharma.shtmlWatson Pharmaceuticals develops, manufactures and markets a comprehensive array of branded and off-patent pharmaceutical products. Watson markets its proprietary products through four divisions: Dermatological, Women's Health, Neuro-Psychiatric and Primary Care.http://www.thelabrat.com/jobs/companies/WatsonPharma.shtmlWatson Pharmaceuticals Incorporatedhttp://www.prplace.com/pr_thread/view/id-116summary : Teva Pharma has a generic version but earlier this year there were some consumer complaints now the FDA has cleared another manufacturer to produce a generic version Watson Pharmaceuticals. Th ...http://www.prplace.com/pr_thread/view/id-116Watson Pharmaceuticals Incorporatedhttp://www.piribo.com/publications/pharmaceutical_companies/watson_pharmaceuticals_inc_deals.htmlPartneringdesk Watson Pharmaceuticals Inc Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005.http://www.piribo.com/publications/pharmaceutical_companies/watson_pharmaceuticals_inc_deals.htmlWatson Pharmaceuticals Incorporatedhttp://www.biospace.com/news_story.aspx?StoryID=47419&full=1Net revenue for the fourth quarter increased 48 percent or $202.4 million to $621.2 million, compared to $418.8 million for the fourth quarter ended December 31, 2005.http://www.biospace.com/news_story.aspx?StoryID=47419&full=1Watson Pharmaceuticals Incorporatedhttp://www.smartbrief.com/news/bio/companyData.jsp?companyId=1121Watson Pharmaceuticals tries to have the best of both worlds, with operations in the booming generics industry and the higher-profit-margin branded drug business.http://www.smartbrief.com/news/bio/companyData.jsp?companyId=1121Watson Pharmaceuticals Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=105650&category=15Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=105650&category=15Watson Pharmaceuticals Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=WPI:US&sid=a_HmDAVDkjC8CORONA, Calif., July 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2007 financial results on Thursday, August 2, 2007 prior to the open of the U.S.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=WPI:US&sid=a_HmDAVDkjC8Watson Pharmaceuticals Incorporatedhttp://sify.com/finance/equity/moreheadlines.php?cid=20753&ctid=2&ccode=NOVSandoz, the generic drugs unit of Novartis, has lost World Health Organisation approval for drugs produced at a South African plant due to manufacturing problems, the U.N. agency said on Monday.http://sify.com/finance/equity/moreheadlines.php?cid=20753&ctid=2&ccode=NOVWatson Pharmaceuticals Incorporatedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=Elan+Corporation+plc+&Image=&symb=WPICopyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=Elan+Corporation+plc+&Image=&symb=WPIWatson Pharmaceuticals Incorporatedhttp://www.bio-medicine.org/medicine-news-1/Radiologists-find-a-technique-to-significantly-reduce-patient-radiation-dose-during-CT-angiography-57719-1/Health, ...Radiologists have discovered that prospective electrocardiogram (ECG) ...The study performed at the Medical College of Wisconsin compared the...Forty patients were evaluated using retrospective gating and 40 more w... Radiation exposure continues to be a concern during CT procedures.http://www.bio-medicine.org/medicine-news-1/Radiologists-find-a-technique-to-significantly-reduce-patient-radiation-dose-during-CT-angiography-57719-1/Watson Pharmaceuticals IncorporatedSun, 20 Sep 2009 18:45:20 GMT